throbber
Case IPR2016-00829
`Patent 9,095,559 B2
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`___________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`___________________
`
`
`
`LUPIN LTD. and LUPIN PHARMACEUTICALS, INC.
`Petitioner,
`
`v.
`
`HORIZON THERAPEUTICS, INC.
`Patent Owner
`
`
`
`Case IPR2016-00829
`Patent 9,095,559 B2
`
`
`
`PETITIONERS’ OBJECTIONS TO EVIDENCE
`PURSUANT TO 37 C.F.R. § 42.64
`
`
`
`
`
`Mail Stop PATENT BOARD
`Patent Trial and Appeal Board
`United States Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`
`
`

`

`
`
`Petitioners Lupin Ltd. and Lupin Pharmaceuticals, Inc. (“Lupin”) hereby
`
`Case IPR2016-00829
`Patent 9,095,559 B2
`
`object pursuant to 37 C.F.R. § 42.64(b)(1) and the Federal Rules of Evidence
`
`(“FRE”) to the admissibility of certain purported evidence served by Patent
`
`Owner’s Horizon Therapeutics, Inc. on February 10, 2017 in connection with its
`
`Response to Lupin’s Petition for Inter Partes Review of U.S. Patent No. 9,095,559
`
`(“the ’559 patent”). The exhibits objected to, and grounds for Lupin’s objections,
`
`are listed below. Lupin also objects to Patent Owner’s reliance on or citations to
`
`any objected evidence in its papers.
`
`Some of the exhibits served by Horizon Therapeutics, Inc. on February 10,
`
`2016 were introduced during the deposition of Keith Vaux in this proceeding, and
`
`Lupin objected to those exhibits at the deposition as required by 37 C.F.R. §
`
`42.64(a). Nothing contained herein shall be deemed to withdraw any of Lupin’s
`
`objections to deposition evidence or the requirement that evidence to cure those
`
`objections must have been provided during the deposition.
`
`I.
`
`IDENTIFICATION OF CHALLENGED EVIDENCE AND GROUNDS
`FOR OBJECTIONS
`A. Exhibit 2001
`Lupin objects to Exhibit 2001 under FRE 402 and 403 because it is
`
`irrelevant and its probative value is substantially outweighed by the danger of
`
`wasting time in this compressed proceeding. Exhibit 2001 is a litigation document
`
`which bears no relevance to the issue of patentability of the ’559 patent claims.
`
`
`
`- 2 -
`
`

`

`
`Lupin further objects to Exhibit 2001 under FRE 802 because it is inadmissible
`
`Case IPR2016-00829
`Patent 9,095,559 B2
`
`hearsay, specifically a complaint in a district court litigation, Horizon
`
`Therapeutics, Inc. v. Lupin Ltd., 1:15-cv-07624-RBK-JS (D.N.J.). Lupin also
`
`objects to Exhibit 2001 under FRE 901 on the basis that it has not been properly
`
`authenticated and lacks foundation.
`
`Exhibit 2002
`
`B.
`Lupin objects to Exhibit 2002 under FRE 402 and 403 because it is
`
`irrelevant and its probative value is substantially outweighed by the danger of
`
`wasting time in this compressed proceeding. Exhibit 2002 is a litigation document
`
`which bears no relevance to the issue of patentability of the ’559 patent claims.
`
`Lupin further objects to Exhibit 2002 under FRE 802 because it is inadmissible
`
`hearsay, specifically an amended complaint in a district court litigation, Horizon
`
`Therapeutics, Inc. v. Lupin Ltd., 1:15-cv-07624-RBK-JS (D.N.J.). Lupin also
`
`objects to Exhibit 2002 under FRE 901 on the basis that it has not been properly
`
`authenticated and lacks foundation.
`
`C. Exhibit 2003
`Lupin objects to Exhibit 2003 as incomplete. It should therefore be
`
`excluded under FRE 106 and 403.
`
`
`
`- 3 -
`
`

`

`
`
`D. Exhibit 2004
`Lupin objects to Exhibit 2004 as incomplete. It should therefore be
`
`Case IPR2016-00829
`Patent 9,095,559 B2
`
`excluded under FRE 106 and 403.
`
`Exhibit 2005
`
`E.
`Lupin objects to Exhibit 2005 under FRE 402 and 403 because it is
`
`irrelevant and its probative value is substantially outweighed by the danger of
`
`wasting time in this compressed proceeding. Exhibit 2005 is a litigation document
`
`served by Par Pharmaceuticals, Inc. in a different proceeding regarding different
`
`patents, and therefore bears no relevance to the issue of patentability of the ’559
`
`patent claims. Lupin further objects to Exhibit 2005 under FRE 802 because it is
`
`inadmissible hearsay, specifically a non-party’s invalidity and non-infringement
`
`contentions in an unrelated district court litigation, Horizon Therapeutics, Inc. v.
`
`Par Pharmaceuticals, Inc., C.A. No. 2:14-cv-00384-JRG-RSP (E.D. Tex). Lupin
`
`also objects to Exhibit 2005 under FRE 901 on the basis that it has not been
`
`properly authenticated and lacks foundation. Lupin further objects to Exhibit 2005
`
`as incomplete because it contains only certain portions of Par Pharmaceutical’s
`
`Invalidity and Non-infringement Contentions, and should therefore be excluded
`
`under FRE 106.
`
`
`
`- 4 -
`
`

`

`
`
`Exhibit 2006
`
`F.
`Lupin objects to Exhibit 2006, the declaration of Dr. Gregory M. Enns,
`
`Case IPR2016-00829
`Patent 9,095,559 B2
`
`under FRE 402 to the extent that it includes or relies on irrelevant or inadmissible
`
`information and under FRE 403 to the extent that it includes or relies on
`
`information that probative value of which is substantially outweighed by the
`
`danger of unfair prejudice, wasting time, or needlessly presenting cumulative
`
`evidence as set forth herein. Lupin further objects to Exhibit 2006 under FRE 901
`
`on the basis that it cites or relies on exhibits that have not been properly
`
`authenticated or lack foundation, as set forth herein.
`
`G. Exhibit 2012
`Lupin objects to Exhibit 2012 under FRE 402 and 403 because it is
`
`irrelevant and its probative value is substantially outweighed by the danger of
`
`wasting time in this compressed proceeding. Exhibit 2012 was published in 2012
`
`and, therefore, bears no relevance to what the person of ordinary skill in the art
`
`would have known by the relevant date, Sept. 30, 2011. Therefore, Exhibit 2012
`
`should be excluded under FRE 402 and 403. Lupin further objects to Exhibit 2012
`
`under FRE 802 on the basis that it is inadmissible hearsay, not within a hearsay
`
`exception.
`
`
`
`- 5 -
`
`

`

`
`
`H. Exhibit 2015
`Lupin objects to Exhibit 2015 under FRE 402 and 403 because it is
`
`Case IPR2016-00829
`Patent 9,095,559 B2
`
`irrelevant and its probative value is substantially outweighed by the danger of
`
`wasting time in this compressed proceeding. Exhibit 2015 is dated after September
`
`30, 2011, and therefore bears no relevance to what the person of ordinary skill in
`
`the art would have known by the relevant date. Therefore, Exhibit 2015 should be
`
`excluded under FRE 402 and 403. Lupin further objects to Exhibit 2015 under
`
`FRE 802 on the basis that it is inadmissible hearsay, not within a hearsay
`
`exception.
`
`Exhibit 2019
`
`I.
`Lupin objects to Exhibit 2019 under FRE 402 and 403 because it is
`
`irrelevant and its probative value is substantially outweighed by the danger of
`
`wasting time in this compressed proceeding. Exhibit 2019 is dated after September
`
`30, 2011, and therefore bears no relevance to what the person of ordinary skill in
`
`the art would have known by the relevant date. Therefore, Exhibit 2019 should be
`
`excluded under FRE 402 and 403. Lupin further objects to Exhibit 2019 under
`
`FRE 802 on the basis that it is inadmissible hearsay, not within a hearsay
`
`exception.
`
`
`
`- 6 -
`
`

`

`
`
`Exhibit 2026
`
`J.
`Lupin objects to Exhibit 2026 under FRE 402 and 403 because it is
`
`Case IPR2016-00829
`Patent 9,095,559 B2
`
`irrelevant and its probative value is substantially outweighed by the danger of
`
`wasting time in this compressed proceeding. Exhibit 2026 is dated after September
`
`30, 2011, and therefore bears no relevance to what the person of ordinary skill in
`
`the art would have known by the relevant date. Therefore, Exhibit 2026 should be
`
`excluded under FRE 402 and 403. Lupin further objects to Exhibit 2026 under
`
`FRE 802 on the basis that it is inadmissible hearsay, not within a hearsay
`
`exception. Lupin also objects to Exhibit 2026 under FRE 901 on the basis that it
`
`has not been properly authenticated and lacks foundation.
`
`K. Exhibit 2027
`Lupin objects to Exhibit 2027 under FRE 402 and 403 because it is
`
`irrelevant and its probative value is substantially outweighed by the danger of
`
`wasting time in this compressed proceeding. Exhibit 2027 does not have a
`
`discernible publication date and Patent Owner has not established that it is prior
`
`art. Absent such a showing, it bears no relevance to what the person of ordinary
`
`skill in the art would have known by the relevant date, Sept. 30, 2011. Therefore,
`
`Exhibit 2027 should be excluded under FRE 402 and 403. Lupin further objects to
`
`Exhibit 2027 under FRE 802 on the basis that it is inadmissible hearsay, not within
`
`
`
`- 7 -
`
`

`

`
`a hearsay exception. Lupin also objects to Exhibit 2027 under FRE 901 on the
`
`Case IPR2016-00829
`Patent 9,095,559 B2
`
`basis that it has not been properly authenticated and lacks foundation.
`
`Exhibit 2029
`
`L.
`Lupin objects to Exhibit 2029 under FRE 402 and 403 because it is
`
`irrelevant and its probative value is substantially outweighed by the danger of
`
`wasting time in this compressed proceeding. Exhibit 2029 is dated after September
`
`30, 2011, and therefore bears no relevance to what the person of ordinary skill in
`
`the art would have known by the relevant date. Therefore, Exhibit 2026 should be
`
`excluded under FRE 402 and 403. Lupin further objects to Exhibit 2026 under
`
`FRE 802 on the basis that it is inadmissible hearsay, not within a hearsay
`
`exception.
`
`M. Exhibit 2033
`Lupin objects to Exhibit 2033 under FRE 402 and 403 because it is
`
`irrelevant and its probative value is substantially outweighed by the danger of
`
`wasting time in this compressed proceeding. Exhibit 2033 does not have a
`
`discernible publication date and Patent Owner has not established that it is prior
`
`art. Absent such a showing, it bears no relevance to what the person of ordinary
`
`skill in the art would have known by the relevant date, Sept. 30, 2011. Therefore,
`
`Exhibit 2033 should be excluded under FRE 402 and 403. Lupin further objects to
`
`
`
`- 8 -
`
`

`

`
`Exhibit 2033 under FRE 802 on the basis that it is inadmissible hearsay, not within
`
`Case IPR2016-00829
`Patent 9,095,559 B2
`
`a hearsay exception. Lupin also objects to Exhibit 2033 under FRE 901, 1002 and
`
`1003 on the basis that it has not been properly authenticated and lacks foundation.
`
`N. Exhibit 2034
`Lupin objects to Exhibit 2034 as incomplete to the extent that it does not
`
`include errata. It should therefore be excluded under FRE 106 and 403.
`
`O. Exhibit 2035
`Lupin objects to Exhibit 2035 under FRE 402 and 403 because it is
`
`irrelevant and its probative value is substantially outweighed by the danger of
`
`wasting time in this compressed proceeding. Exhibit 2035 has no discernible
`
`publication date and Patent Owner has not established that it is prior art. Absent
`
`such a showing, it bears no relevance to what the person of ordinary skill in the art
`
`would have known by the relevant date, Sept. 30, 2011. Therefore, Exhibit 2035
`
`should be excluded under FRE 402 and 403. Lupin further objects to Exhibit 2035
`
`under FRE 802 on the basis that it is inadmissible hearsay, not within a hearsay
`
`exception. Lupin also objects to Exhibit 2035 under FRE 901 on the basis that it
`
`has not been properly authenticated and lacks foundation.
`
`- 9 -
`
`
`
`
`
`

`

`
`
`Exhibit 2036
`
`P.
`Lupin objects to Exhibit 2036 under FRE 402 and 403 because it is
`
`Case IPR2016-00829
`Patent 9,095,559 B2
`
`irrelevant and its probative value is substantially outweighed by the danger of
`
`wasting time in this compressed proceeding. Lupin also objects to Exhibit 2036
`
`under FRE 901, 1002 and 1003 on the basis that it has not been properly
`
`authenticated and lacks foundation.
`
`Q. Exhibit 2037
`Lupin objects to Exhibit 2037 under FRE 402 and 403 because it is
`
`irrelevant and its probative value is substantially outweighed by the danger of
`
`wasting time in this compressed proceeding. Lupin also objects to Exhibit 2037
`
`under FRE 901 on the basis that it has not been properly authenticated and lacks
`
`foundation.
`
`R. Exhibit 2038
`Lupin objects to Exhibit 2038 under FRE 402 and 403 because it is
`
`irrelevant and its probative value is substantially outweighed by the danger of
`
`wasting time in this compressed proceeding. Exhibit 2038 does not have a
`
`discernible publication date and Patent Owner has not established that it is prior
`
`art. Absent such a showing, it bears no relevance to what the person of ordinary
`
`skill in the art would have known by the relevant date, Sept. 30, 2011. Therefore,
`
`Exhibit 2038 should be excluded under FRE 402 and 403. Lupin further objects to
`
`
`
`- 10 -
`
`

`

`
`Exhibit 2038 under FRE 802 on the basis that it is inadmissible hearsay, not within
`
`Case IPR2016-00829
`Patent 9,095,559 B2
`
`a hearsay exception. Lupin also objects to Exhibit 2038 under FRE 901 on the
`
`basis that it has not been properly authenticated and lacks foundation.
`
`Exhibit 2041
`
`S.
`Lupin objects to Exhibit 2041 under FRE 402 and 403 because it is
`
`irrelevant and its probative value is substantially outweighed by the danger of
`
`wasting time in this compressed proceeding. Exhibit 2041 is dated after September
`
`30, 2011, and therefore bears no relevance to what the person of ordinary skill in
`
`the art would have known by the relevant date. Therefore, Exhibit 2041 should be
`
`excluded under FRE 402 and 403. Lupin further objects to Exhibit 2041 under
`
`FRE 802 on the basis that it is inadmissible hearsay, not within a hearsay
`
`exception. Lupin also objects to Exhibit 2041 under FRE 901 on the basis that it
`
`has not been properly authenticated and lacks foundation.
`
`Exhibit 2042
`
`T.
`Lupin objects to Exhibit 2042 under FRE 402 and 403 because it is
`
`irrelevant and its probative value is substantially outweighed by the danger of
`
`wasting time in this compressed proceeding. Exhibit 2042 is dated after September
`
`30, 2011, and therefore bears no relevance to what the person of ordinary skill in
`
`the art would have known by the relevant date. Therefore, Exhibit 2042 should be
`
`
`
`- 11 -
`
`

`

`
`excluded under FRE 402 and 403. Lupin further objects to Exhibit 2042 under
`
`Case IPR2016-00829
`Patent 9,095,559 B2
`
`FRE 802 on the basis that it is inadmissible hearsay, not within a hearsay
`
`exception.
`
`U. Exhibit 2045
`Lupin objects to Exhibit 2045 under FRE 402 and 403 because it is
`
`irrelevant and its probative value is substantially outweighed by the danger of
`
`wasting time in this compressed proceeding. Exhibit 2045 has no discernible
`
`publication date and Patent Owner has not established that it is prior art. Absent
`
`such a showing, it bears no relevance to what the person of ordinary skill in the art
`
`would have known by the relevant date, Sept. 30, 2011. Therefore, Exhibit 2045
`
`should be excluded under FRE 402 and 403. Lupin further objects to Exhibit 2045
`
`under FRE 802 on the basis that it is inadmissible hearsay, not within a hearsay
`
`exception. Lupin also objects to Exhibit 2045 under FRE 901 on the basis that it
`
`has not been properly authenticated and lacks foundation.
`
`- 12 -
`
`
`
`
`
`

`

`Case IPR2016-00829
`Patent 9,095,559 B2
`
`Respectfully submitted,
`
`/Cynthia Lambert Hardman/
`Elizabeth J. Holland (Reg. No. 47,657)
`Cynthia Lambert Hardman (Reg. No.
`53,179)
`GOODWIN PROCTER LLP
`The New York Times Building
`620 Eighth Avenue
`New York, NY 10018
`(212) 813-8800 (telephone)
`(212) 355-3333 (facsimile)
`
`Counsel for Petitioners
`
`
`
`
`
`
`
`
`Dated: February 17, 2016
`
`
`
`- 13 -
`
`

`

`
`
`CERTIFICATE OF SERVICE
`
`Case IPR2016-00829
`Patent 9,095,559 B2
`
`The undersigned hereby certifies that PETITIONERS’ OBJECTIONS TO
`
`EVIDENCE PURSUANT TO 37 C.F.R. 42.64 was served electronically via email
`
`on February 17, 2017 on the following:
`
`James B. Monroe (lead counsel, Reg. No. 33,971)
`Maureen D. Queler (backup counsel, Reg. No. 61,879)
`FINNEGAN, HENDERSON, FARABOW, GARRETT & DUNNER, LLP
`James.monroe@finnegan.com
`Maureen.queler@finnegan.com
`
`
`
`Matthew Phillips (backup counsel, Reg. No. 43,403)
`Renaissance IP Law Group LLP
`matthew.phillips@renaissanceiplaw.com
`
`
`
`Robert Green (Reg. No. 27,555)
`Emer Simic (Reg. No. 61,235)
`Green, Griffith & Borg-Breen, LLP
`rgreen@greengriffith.com
`esimic@greengriffith.com
`
`Dated: February 17, 2017
`
`
`
`/Cynthia Lambert Hardman/
`Cynthia Lambert Hardman
`
`
`
`- 14 -
`
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket